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Allergic diseases are caused by an inappropriate initiation of Type 2 (T~H~2) immune responses to innocuous environmental antigens that affect the upper airway mucosa (rhinitis), lung (asthma), the gut (food allergy), and the skin (dermatitis) (Julia et al. [@CR15]). Over the last two to three decades, the prevalence of allergic diseases has significantly increased and this has often been explained by a decline in infections during early life. It is thought that those who have had bacterial and viral infections during childhood are able to direct their maturing immune system (Table [11.1](#Tab1){ref-type="table"}) toward a T~H~1 type and counterbalance any pro-allergic responses of T~H~2 cells (Yazdanbakhsh et al. [@CR31]). The induction of a robust anti-inflammatory regulatory network by early life exposure to allergens offers a solution to the inverse association of allergen exposure with allergic disorders (Du Toit et al. [@CR8]; Wu et al. [@CR30]).Table 11.1Composition of the immune systemImmune organsImmunocytesImmune moleculesCentral immune organPeripheral immune organMembrane surface moleculesSecretory moleculeThymusSpleenStem cell lineTCRImmunoglobulinLymphocyteBCRMarrowLymph nodeMononuclear phagocyteCD moleculeComplementBursa of Fabricius (birds)Mucosa-associated lymphoid tissueOther APC (dendritic cell, endothelial cell, etc.)Adhesion moleculeCytokinesSkin-associated lymphoid tissueOther immune cells (granulocyte, mast cell, platelet, erythrocyte, etc.)MHC, etc.

Differentiation of Antigenicity, Immunogenicity and Allergenicity {#Sec2}
=================================================================

In textbooks, an antigen, also called an immunogen in some references, is a substance that binds to a specific antibody or is any molecule or molecular fragment that can be bound by a major histocompatibility complex (MHC) and presented to a T cell receptor (TCR). Two features, antigenicity and immunogenicity, are generally used to describe each antigen. Immunogenicity is the ability to induce a humoral and/or cell-mediated immune response. Antigenicity is the ability to specifically combine with the final products of the immune response (i.e., secreted antibodies and/or surface receptors on T cells) (Owen et al. [@CR23]). Although all molecules that are immunogenic are also antigenic, the reverse is not true.

If we carefully contemplate these two characteristics that are used to define an antigen, we discover that immunogenicity and antigenicity are tightly related and are always duplicated. Antibodies are produced as the result of immune induction, not from thin air. And antigens cannot trigger an immune response unless they bind with their corresponding antibodies or receptors. The above two concepts simply and repeatedly describe a single generality of all antigens, yet this alone does not allow us to completely characterize various antigens and cannot help us to understand antigens in various guises. However, different antigens produce different immune responses as they encounter their antibodies or receptors. Using this feature, antigens can be more accurately defined by the difference in the type of immune responses they induce.

According to the classical definition of immunology, the major function of the immune system, as in the integrated anatomic system and other systems, is to avoid disease in the human body. The immune system has its own mechanisms for maintaining a general physiological balance in life by co-operating with other systems of the body. Here, we attempt to redefine and differentiate antigenicity into immunogenicity and allergenicity. We refer to antigenicity as the ability of an antigen to induce an immunological response when it is encountered by the human body. Antigenicity involves two types of immune characteristics, immunogenicity, and allergenicity. Immunogenicity refers to the ability of an antigen to trigger normal and protective immune responses after being encountered by the human body. We describe the immunogenicity of an antigen using the following three aspects: (1) the ability to defend the immune system (**immunological defense**), which is the ability to repel an exogenous antigen and to fight against infection; (2) the ability to keep the immune system stable (**immunological homeostasis**), which is the ability of the body to recognize and eliminate damaged tissue, inflammation and/or senescent cells, and (3) the ability to kill and to remove abnormally mutated cells so as to monitor and inhibit the growth of malignancies in the body (**immunological surveillance**). Thus, immunogenicity reflects the strength of these three functions.

Allergenicity refers to the ability of an antigen to induce an abnormal immune response, which is an overreaction and different from a normal immune response in that it does not result in a protective/prophylaxis effect but instead causes physiological function disorder or tissue damage.
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How to Measure *Allergenicity*? {#Sec3}
===============================

Allergenicity, like immunogenicity, also exhibits antigen specificity. Due to different antigen/antibody specificities, each antigen has different levels of allergenicity and immunogenicity and each individual has a different immune system, thus, antigens can be allergens in individuals of different ages and different immune statuses. In general, the most potent allergens are proteins, with polysaccharides ranking second.

Allergy usually is characterized by T~H~2 (T helper 2) responses, which are described by increases in the levels of interleukin (IL)-4 and other T~H~2-type cytokines (IL-5, IL-9, IL-13, and IL-21, etc.), activation and expansion of CD4+ T~H~2 cells, induction of plasma cells secreting IgE, and activation of eosinophils, mast cells, and basophils, all of which can produce several types of T~H~2-type cytokines (Anthony et al. [@CR2]). Hence, the levels and duration of the T~H~2 response define allergenicity.

Researchers can also ascertain a protein's identity by scrutinizing its history of medical use or by searching the literature to see whether any adverse reactions have been reported or by doing experiments to investigate the allergenicity and immunogenicity of the candidate protein(s) to be encountered by the human body. Literature reviewing also provides bioinformatics data that can be used to evaluate immunogenicity and allergenicity.

Important Factors for Early Exposure and Hygiene Hypothesis {#Sec4}
===========================================================

Allergies are a major cause of chronic disease in all countries of the world with the incidence of reported cases significantly increasing over the past two to three decades. This increase has often been explained by some experts as the Hygiene Hypothesis (Cramer et al. [@CR6]; Liu and Murphy [@CR18]; Maizels et al. [@CR19]; Sherriff and Golding [@CR27]), that is, a decline in infections during early life could predispose children to be susceptible to allergy and that exposure to microbial products such as endotoxin can reduce the risk for allergic sensitization during early childhood. However, on the contrary, allergic sensitization among adults and in the elderly increased with increasing endotoxin levels (Min and Min [@CR22]). The same observation has been made for the development of food allergy. Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy (Du Toit et al. [@CR8], [@CR9]). Higher maternal intake of peanut, milk, and wheat during early pregnancy was associated with a decreased incidence of mid-childhood allergy and asthma (Bunyavanich et al. [@CR3]). The role of diet, therefore, has been highlighted as a key factor that influences immune homeostasis and the development of allergic diseases (Julia et al. [@CR15]). There is no benefit to delaying the introduction of any potentially allergenic food, such as milk, eggs, peanuts, or fish food beyond 6 months of age to prevent food allergy (Chin et al. [@CR5]). Regarding the development of inhalant allergy, a similar conclusion has been drawn but with an exception for mites. It was demonstrated that early exposure to high levels (≥10 µg/g dust) of dust mite allergen was associated with an increased risk of asthma and late-onset wheeze at age 7 years compared with exposure to low levels (\< 0.05 µg/g dust) of dust mite allergen (Celedon et al. [@CR4]). Also, pet exposure during the first year of life and an increasing number of siblings were both associated with a lower prevalence of allergic rhinitis and asthma in school children (Hesselmar et al. [@CR14]).

Some experts have argued that appropriately targeted allergic hypersensitivity evolved to elicit anticipatory responses and to promote avoidance of suboptimal environmental substances (Palm et al. [@CR24]). However, if allergen avoidance really benefited the immune system, there would not be a need for the immune system to establish immune memory. On the other hand, different allergens belong to different groups (see Chap. 10.1007/978-94-017-7444-4_5 in this book). Single-allergen avoidance means avoiding an entire group of allergens, making complete avoidance impossible. Moreover, complete avoidance can cause malnutrition, mental retardation and lost enjoyment of life (Wang [@CR29]). Even worse, avoiding the consumption of certain substances may trigger defects in the immune system. In fact, our meta-analysis concluded that allergen avoidance may not always be successful in preventing allergic symptoms (Wu et al. [@CR30]), especially for newborns.

A study of the prevalence of allergy in adults demonstrated that infection with pulmonary TB contributes significantly to atopy, particularly allergic rhinitis symptoms (Lin et al. [@CR17]). A pilot experiment showed the cross-reactivity between antigens from roundworm *Ascaris lumbricoides* (AL) and house dust mite (HDM) allergens (Acevedo et al. [@CR1]). Another experiment with larger samples further demonstrated that AL-antigens can inhibit up to 92 % of HDM-specific IgE-reactivity among allergic subjects, while only up to 54 % of AL-specific IgE-reactivity among ascariasis subjects was inhibited by HDM allergens (Valmonte et al. [@CR28]), suggesting that AL antigens have broader and higher allergenicity than HDM allergens and noting that the latter would sensitize up to 70 % of the allergic population (He et al. [@CR13]). A further study from Hagel I et al. indicates that it only took a mild infection with *A. lumbricoides* (0--5000 eggs/g feces) to significantly elevate the levels of IL-13, IL-6, IL-10 as well as the levels of IFN-γ and no mention of IgE or IgG in this group, while in the moderately infected group (\> 5001--50,000 eggs/g feces), IL-13 and IL-10 are very significantly increased but no increase of IgE, IgG, IFN-γ, or IL-6 was observed in comparison with those in the urban nonparasitized control group. This result indicated that the protective response against allergy development by *A. lumbricoides* relies on IL-10 but is independent of the production of IFN-γ, IgE, or IgG. These observations are complicated by concurrent infections with *Giardia duodenalis* and *A. lumbricoides*. A study evaluated the effect of *A. lumbricoides* on *G. duodenalis* infection and T~H~1/T~H~2 type immune mechanisms toward this parasite in 251 rural parasitized and 70 urban nonparasitized school children (Hagel et al. [@CR12]). In the group of children mildly infected with *A. lumbricoides*, the levels of IgG, IgE, IL-13, IL-6, IL-10, IFN-γ, and IL-6 are all very significantly increased, while in the group of children moderately infected with *A. lumbricoides*, only IL-13 and IL-10 are highly elevated and IFN-γ is significantly increased but with no significant effects on the levels of IgG, IgE, or IL-6. These results suggest that *A. lumbricoides* can modulate the immune responses by affecting both T~H~1 and T~H~2 type immunity (Hagel et al. [@CR12]). Therefore, the conditions regarding the severity of the *A. lumbricoides* infection and whether or not co-infection with other species of parasites has occurred are very important in reaching the real conclusion. This information would have been helpful in a study (Palmer et al. [@CR25]) that demonstrated in a cross-sectional sample of 2164 children that *A. lumbricoides* infection is associated with increased risk of childhood asthma and atopy in rural China but it did not contain detailed data on the above-mentioned two parameters. This could explain why previous studies of birth cohorts with participants in (sub)-urban environments that examined similar associations have yielded inconsistent results. In conclusion, the protective immune response induced by parasites in humans is dependent on the particular parasite (Ek et al. [@CR10]) and, therefore, discussion of the protective effects without the antibody and cytokine measurements (IgG, IgE, IL-13, IL-6, IL-10, IFN-γ and IL-6) or investigation into the presence of co-infection is limited and insufficient. It is tempting to conclude that *A. lumbricoides* has high immunogenicity and low allergenicity and that this type of circumstance could significantly contribute to the maturation of our immune systems.

Pet exposure during the first year of life and an increased number of siblings were both associated with a lower prevalence of allergic rhinitis and asthma in school children (Hesselmar et al. [@CR14]). Moreover, there is no benefit to delaying the introduction of any potentially allergenic food, such as milk, eggs, peanuts, or fish food beyond 6 months of age to prevent food allergy (Chin et al. [@CR5]). In any case, it should be emphasized that early exposures to prevent the development of allergy should be with allergens, probiotics and non-infectious microbes (Douwes et al. [@CR7]) but without exposure to bio-contaminants (such as biomass smoke), as these can obviously reduce lung function in young adults compared to exposure to smoke from liquefied petroleum gas (Kurmi et al. [@CR16]).

Furthermore, the phenomenon of allergic sensitization is overrepresented among first-born or only children and less frequent in children from large families and those attending day care, suggesting that the frequent exchange of infections may protect children from allergic sensitization (Yazdanbakhsh et al. [@CR31]). A study of gut commensals demonstrates that different rates of microbial colonization and infections with different bacterial types (*Clostridia* vs. *Lactobacilli*) would predispose children to allergy or no allergy (Sepp et al. [@CR26]). This is similar to the situation seen with parasitic infections in children. **The protective effect of infections strictly depends on the specific species and the microbial/parasitic burden**. Thus, it is tempting to think that for immune system development and homeostasis, there are microbial and parasitic friends and foes that are very distinct and explicit. Therefore, **to better characterize the antigen, it is crucial to know how harmful (allergenic) and how beneficial (immunogenic) the antigen is to the immune system**.

Regarding mechanisms, early exposure to soil, house dust, and decaying plants increases gut microbial diversity and decreases serum immunoglobulin E levels, thus enhancing innate immunity (Zhou et al. [@CR32]). Exposure to a non-hygienic environment did not induce significant airway neutrophilia, yet it altered the number of immunologically active cells in the lung and reduced subsequent allergic inflammation (George et al. [@CR11]). Further studies suggested that early exposure to unhygienic conditions and infections is associated with different expression of Toll-like receptors (Majak et al. [@CR20]) and early exposure to a farm environment seems to influence methylation patterns in distinct genes (Michel et al. [@CR21]), therefore, epigenetic mechanisms may contribute to the development of asthma and other allergies.

Balanced Stimulation by Whole Antigens for Immune System Development {#Sec5}
====================================================================

Based on what has been stated for early exposure factors in the previous sections, allergen number reduction results (see Chap. 10.1007/978-94-017-7444-4_5 in this book), and the Hygiene Hypothesis, we hypothesized that **Balanced Stimulation by Whole Antigens is necessary for healthy immune system development**. This hypothesis contains three essential parts: (1) Administration of all types of allergens in very early life contributes to the healthy maturation of the immune system and protects children from allergy development; those infants who miss exposure to one or some types of allergens during the key period of immune system expansion may develop atopy to these substances when they grow up. After a diagnosis of allergy, the affected cases would be treated by immunotherapy with these allergens. (2) Regarding mechanisms, the maternal immune status is a key factor in whether the fetus is primed for a T~H~1 or T~H~2 response. A balanced level of T~H~1 cytokines (IFN-γ, IL-10) provided by maternal T cells drives the direction of the homeostatic development of the initial T~H~0 cells of the fetus that are then further educated for tolerance during infancy and improved by a balanced stimulation with all types of allergens, even if the developing immune status is T~H~2-biased. Conversely, an unbalanced stimulation that lacks of one or more types of allergens in the first year of life would negatively influence the evolving balance and/or enhance any existing T~H~2-biased immune status, thus allowing the development of allergic disease. Furthermore, maternal milk, a tight link between mothers and their children, contains free dietary and environmental allergens, IgM/IgG/IgA, tolerogenic factors (such as interleukin 10, transforming growth factor-β (TGF-β), lactoferrin, antioxidants, etc.), gut growth factors (such as cortisol, thyroxine, epidermal growth factor, TGF-β, etc.) and microbiota-influencing factors (such as prebiotics, oligosaccharides, casein, etc.). These factors can be transferred to the infant during breastfeeding. During childhood and adolescence (Fig. [11.1](#Fig1){ref-type="fig"}), tolerance develops to dietary and inhalant allergens and reinforces the immune system memory to these antigens (Julia et al. [@CR15]). (3) There is a necessity for lasting memory T cells to be restimulated in order to sustain their immortality and immunotolerance capability. It is the exposure of antigens in a certain space-time continuum that stimulate and reinforce the development of the immune system. During the naïve stage, early exposure to superantigens with attenuated allergenicity could potentially strengthen and confer immune system tolerance to their allergenicity-untouched natural counterparts---this is similar to the process of allergen-specific immunotherapy. A good example comes from the progression of smallpox vaccination (Fig. [11.2](#Fig2){ref-type="fig"}). Smallpox vaccines were originally made with whole smallpox virus that then evolved over generations to being made with the cowpox virus, which was actually a type of allergenicity attenuation that resulted in a vaccine that could therefore be safely administered to humans for protection against the smallpox virus (Fig. [11.2](#Fig2){ref-type="fig"}). It is tempting to speculate that other infectious diseases (SARS, AIDS, Ebola, etc.) could be eradicated by vaccination with their allergenicity-attenuated counterparts.Fig. 11.1Possible mechanisms of mother-to-offspring transfer of protection against allergy. Adapted from the reference (Julia et al. [@CR15]). Maternal milk, a tight link between mothers and their children, contains free dietary and environmental allergens, IgM/IgG/IgA, tolerogenic factors (such as interleukin 10, transforming growth factor-β (TGF-β), lactoferrin, antioxidants, etc.), gut growth factors (such as cortisol, thyroxine, epidermal growth factor, TGF-β, etc.) and microbiota-influencing factors (such as prebiotics, oligosaccharides, casein, etc.). These factors can be transferred to the infant during breastfeeding. During childhood and adolescence, tolerance develops to dietary and inhalant allergens and reinforces the immune system memory to these antigens, otherwise the body could become allergic to these allergens/antigens along with the gradual induction of immune tolerance. Allergic disease would march onward if the adult immune system is not able to be tolerant to the allergens. In any case, the adult immune system also needs to be fostered by sustained antigen stimulation to avoid any damage to immune homeostasis. Nevertheless, the allergic status can be modified/reduced and the immune system enhanced/reinforced by immunotherapy with microbial and other exogenous antigens that can attenuate allergenicity Fig. 11.2Smallpox vaccines evolved from an original primitive type to fostered and purified vaccine lymph. The real essence lies in attenuation of the allergenicity

What Is the Future? Can We Ever Win? {#Sec6}
====================================

Increasing allergic reactions have been described as the "Allergy March," which is the progression of atopic manifestations persisting over years and is characterized by a typical sequence of clinical symptoms from colic during infancy (tummy pains, including bad stomach aches, vomiting and diarrhea, itchiness on the baby's face, lips and buttocks, etc.), to eczema when the child is under two-three years old (itchy skin as well as reactions to certain foods and allergens in the air), to rhinitis and then asthma. Nevertheless, we can safely heal this kind of disease by etiological immunotherapy with allergenicity-attenuated vaccines.

We have seen through vaccination that we can strengthen our immune system (Table [11.1](#Tab1){ref-type="table"}) enough to protect us against all types of infectious diseases. It is conceivable that we can also protect from allergy development by early exposure to allergenicity-attenuated vaccines that have been genetically engineered from the environmental antigens. Thus, it is possible that **Immune Giants** could be created that would train our immune systems to be ready to handle all types of environmental antigens, no matter whether they are allergens or infectious microbes (Fig. [11.1](#Fig1){ref-type="fig"}). Regardless, the control of exposure to environmental antigens and undesirable commensal microorganisms will always be an important and challenging part of human health.
